The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEbiquity Regulatory News (EBQ)

Share Price Information for Ebiquity (EBQ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.50
Bid: 41.00
Ask: 42.00
Change: 0.50 (1.22%)
Spread: 1.00 (2.439%)
Open: 41.00
High: 41.50
Low: 41.00
Prev. Close: 41.00
EBQ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Postponement of Results and COVID 19 update

24 Mar 2020 07:00

RNS Number : 2934H
Ebiquity PLC
24 March 2020
 

Ebiquity PLC

 

("Ebiquity" or "the Company")

 

Postponement of Results and COVID 19 update

 

Following the request by the FCA that all listed companies observe a moratorium on the publication of preliminary financial statements for at least two weeks, the preliminary results for Ebiquity will be delayed from the previously planned date of publication on Thursday 26th March 2020. Notification of a new publication date will follow when further guidance from the FCA and other regulatory authorities is available.

 

Ebiquity's global business is continuing to deliver services to clients as usual, with staff in most of our offices worldwide now working remotely, supported by our global IT systems. We are pleased though that our staff in China and Singapore are now returning to office-based working.

 

As previously announced on 19 February 2020, Ebiquity's trading for the year ended 31 December 2019 was in line with expectations with the second half performance trend similar to the first half of the year. Whilst the audit is not yet complete, if announcing preliminary results today, Ebiquity would be expecting to report, on a going concern basis, revenue of £68.7 million and Adjusted Operating Profit of £6.2 million.

 

Following the disposal of Ad Intel in January 2019, Ebiquity has a considerably stronger balance sheet. Net debt at 31 December 2019 was £5.8 million, (compared to £28 million prior to the disposal of Ad Intel). At that date, its cash balances were £8.2m. The Group has committed banking facilities of £24 million, whose maturity date is in 2023, of which £14 million was drawn down as at 31 December 2019.

 

Trading in the current year has started in line with the Board's expectations. However, the rapidly developing Covid-19 global outbreak is clearly creating uncertainty over the coming months for our clients' businesses, which cover many sectors and geographies, as well as our own. The Board therefore believes it prudent at this stage to withdraw guidance on the Group's overall performance in 2020.

 

Rob Woodward, Chairman commented:

 

"We are extremely proud of all of our staff who have shown great resilience and flexibility in responding to the challenges of the Covid-19 outbreak. The Board thanks all Ebiquity's global teams for their continued commitment and determination to deliver high quality professional service and independent media advice to our clients during this difficult time."

 

 

Enquiries:

 

Ebiquity plc

Alan Newman (Interim Chief Executive Officer)

Mark Sanford (Company Secretary)

 

Via Instinctif Partners

 

Instinctif Partners

Matthew Smallwood

Guy Scarborough

 

020 7457 2020

Numis Securities Limited

Nick Westlake (NOMAD)

Matt Lewis

020 7260 1000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDDGGDXSUDDGGX
Date   Source Headline
27th Nov 20147:00 amRNSExercise of Share Options
24th Nov 20143:00 pmRNSDirector Dealing
24th Nov 20142:59 pmRNSHolding(s) in Company
24th Nov 20142:55 pmRNSDirector Dealing and Exercise of Share Options
21st Nov 20147:00 amRNSAppointment of Non-Executive Directors
21st Nov 20147:00 amRNSTrading update
14th Nov 20143:22 pmRNSDirector Dealing
11th Nov 20149:10 amRNSDirector Dealing
10th Sep 201411:57 amRNSResult of AGM
6th Aug 20147:00 amRNSAnnual Report
31st Jul 20143:49 pmRNSHolding(s) in Company
16th Jul 20147:00 amRNSFinal Results
3rd Jul 20147:00 amRNSNew Debt Facility
13th Jun 20148:30 amRNSAppointment of MD, South East Asia
16th May 201411:33 amRNSAward of share options
8th May 20147:00 amRNSAcquisition
14th Apr 20147:00 amRNSAppointment of CEO, Americas
7th Apr 20147:00 amRNSPayment of deferred consideration
19th Mar 20147:00 amRNSChange of Registered Office
13th Mar 20143:05 pmRNSHolding(s) in Company
11th Mar 20145:32 pmRNSExercise of Share Options
7th Mar 20141:04 pmRNSExercise of Share Options
7th Mar 20147:00 amRNSDirectors' dealings and directorate changes
6th Mar 20147:00 amRNSDirectorate
3rd Mar 201412:02 pmRNSHolding(s) in Company
21st Feb 20149:32 amRNSHolding(s) in Company
20th Feb 20145:45 pmRNSHolding in Company / Issue of Equity
13th Feb 201411:00 amRNSHolding in Company / Issue of Equity
13th Feb 201410:24 amRNSHolding(s) in Company
12th Feb 201410:34 amRNSHolding(s) in Company
7th Feb 201412:50 pmRNSHolding(s) in Company
7th Feb 201412:10 pmRNSHolding(s) in Company
6th Feb 201412:02 pmRNSHolding(s) in Company
5th Feb 20144:49 pmRNSHolding(s) in Company
22nd Jan 20145:34 pmRNSExercise of Share Options
21st Jan 20144:06 pmRNSExercise of Share Options
17th Jan 20144:24 pmRNSDirector/PDMR Shareholding
15th Jan 20147:00 amRNSInterim Results
15th Jan 20147:00 amRNSAcquisition
15th Jan 20147:00 amRNSConclusion of Review of Strategic Options
14th Jan 20149:02 amRNSForm 8.5 (EPT/RI)
8th Jan 20148:30 amRNSNotice of Interim Results
7th Jan 20148:53 amRNSForm 8.5 (EPT/RI)
2nd Jan 20148:45 amRNSForm 8.5 (EPT/RI)
19th Dec 20138:56 amRNSForm 8.5 (EPT/RI)
10th Dec 20138:45 amRNSForm 8.5 (EPT/RI)
5th Dec 20139:07 amRNSForm 8.5 (EPT/RI)
4th Dec 20139:04 amRNSForm 8.5 (EPT/RI)
29th Nov 20138:45 amRNSForm 8.5 (EPT/RI)
26th Nov 20139:15 amRNSForm 8.5 (EPT/RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.